Taro Pharmaceutical Industries Ltd's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2023 to a ratio of 2.13, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Taro Pharmaceutical Industries Ltd in Mar 31 2023 quarter, has decreased to 171 days, compared to 216 days, in the 0 quarter.

If we take a look into Healthcare sector 564 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 0 to 3555.

What is Receivable Turnover Ratio?
What is Taro Pharmaceutical Industries Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TARO Receivables Turnover Ratio	(Mar 31 2023) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2022) IV. Quarter
Y / Y Receivable Change	-55.25 %	-5.28 %	-5.28 %	120.73 %	7.85 %
Y / Y Revenue Change	2.07 %	-	-	-	2.25 %
Receivable Turnover Ratio (TTM)	2.13	1.69	1.68	1.66	2.06
TARO's Total Ranking	# 3555	# 0	# 3514	# 2915	# 0
Accounts Receivable average collection period days	172	216	218	220	178
Seq. Receivable Change	0 %	0 %	-57.09 %	4.3 %	111.64 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 204
Healthcare Sector	# 565
Overall Market	# 3555

Receivable Turnover Ratio Statistics
High	Average	Low
3.98	3.08	2.57
(Mar 31 2016)		(Mar 31 2021)

TARO Company Profile • Back to TARO Efficiency Comparisons • Compare TARO Receivables Turnover Ratio to its Competitors

Financial Statements
Taro Pharmaceutical Industries Ltd's Accounts Receivable	$ 202 Millions	Visit TARO's Balance sheet
Taro Pharmaceutical Industries Ltd's Sales TTM	$ 573 Millions	Visit TARO's Income Statement
Sources of TARO's Revenues		Visit TARO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TARO's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TARO's Growth Rates	TARO's Roa	TARO's Inventory Turnover Ratio	TARO's Dividend Comparisons
TARO's Profitability Ratios	TARO's Roi	TARO's Asset Turnover Ratio	TARO's Dividend Growth
TARO's Valuation Ratios	TARO's Roe	TARO's Financial Strength Ratios	TARO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Nexgel Inc	7.79	$ 2.272 Millions	$ 0.292 Millions
Addus Homecare Corp	7.78	$ 976.085 Millions	$ 125.437 Millions
Aveanna Healthcare Holdings Inc	7.77	$ 1,803.524 Millions	$ 232.085 Millions
Dynatronics Corporation	7.77	$ 43.363 Millions	$ 5.584 Millions
Lensar Inc	7.74	$ 34.270 Millions	$ 4.428 Millions
Apellis Pharmaceuticals Inc	7.72	$ 105.887 Millions	$ 13.710 Millions
Vapotherm Inc	7.70	$ 62.910 Millions	$ 8.173 Millions
Elite Pharmaceuticals Inc	7.69	$ 32.383 Millions	$ 4.209 Millions
Quest Diagnostics Inc	7.65	$ 9,603.000 Millions	$ 1,255.500 Millions
Moderna Inc	7.64	$ 15,059.000 Millions	$ 1,971.000 Millions
Alpha Teknova Inc	7.61	$ 39.394 Millions	$ 5.177 Millions
Lemaitre Vascular Inc	7.60	$ 169.165 Millions	$ 22.260 Millions
Yunhong Green Cti Ltd	7.60	$ 17.302 Millions	$ 2.277 Millions
Akoya Biosciences Inc	7.59	$ 79.375 Millions	$ 10.456 Millions
Inari Medical Inc	7.59	$ 412.886 Millions	$ 54.390 Millions
Atrion Corporation	7.59	$ 176.361 Millions	$ 23.238 Millions
Alpha Pro Tech Ltd	7.57	$ 58.120 Millions	$ 7.682 Millions
Talis Biomedical Corporation	7.56	$ 2.843 Millions	$ 0.376 Millions
Encompass Health Corporation	7.56	$ 4,175.400 Millions	$ 552.525 Millions
Marker Therapeutics inc	7.53	$ 12.784 Millions	$ 1.698 Millions
Palvella Therapeutics Inc	7.52	$ 16.850 Millions	$ 2.239 Millions
Tandem Diabetes Care Inc	7.52	$ 794.693 Millions	$ 105.670 Millions
Axonics Inc	7.49	$ 295.932 Millions	$ 39.523 Millions
Cartesian Therapeutics Inc	7.46	$ 82.716 Millions	$ 11.089 Millions
Avid Bioservices Inc	7.46	$ 148.480 Millions	$ 19.912 Millions
Amedisys Inc	7.46	$ 2,234.331 Millions	$ 299.698 Millions
Inogen Inc	7.44	$ 369.018 Millions	$ 49.572 Millions
AnTix Holdings, Inc.	7.41	$ 1.640 Millions	$ 0.221 Millions
Exelixis Inc	7.40	$ 1,663.870 Millions	$ 224.781 Millions
Sotera Health Company	7.39	$ 987.523 Millions	$ 133.585 Millions

Date modified: 2023-06-30T08:25:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.